MED

Dược Trung ương Mediplantex ·HNX ·2026Q1

▲▲ Improving positively

Operating efficiency is improving Net margin 4.65%, +1.39pp YoY
Price
18,400
Latest close
13 May 2026
P/E 10.77x
P/B 0.68x
EPS 1,709
BVPS 27,175
ROE 6.3%
ROA 4.5%
Profit Margin 4.7%
Asset Turnover 0.97x
Equity Mult. 1.40x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a TTM 2026Q1 basis, MED is improving on both growth and profitability, painting a notably more positive picture versus the same period — profit is at an all-time high. When both scale and efficiency improve together, this is typically a sign of quality growth.

TTM REVENUE
VND 456bn
+10.1%YoY
NET MARGIN
4.65%
+1.4ppYoY
TTM NET PROFIT
VND 21bn
+57.2%YoY
Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Revenue 88.7 117.6 87.1 162.3 75.4 105.9 92.2 140.3 105.0 111.3 106.1 96.6
Growth -25% +35% -46% +115% -29% +15% -34% +34% -6% +5% +10%
Net Income 5.9 6.1 3.9 5.2 2.2 2.9 3.5 4.9 3.8 4.1 3.4 3.3
Net Margin 6.68% 5.22% 4.49% 3.22% 2.89% 2.74% 3.78% 3.50% 3.65% 3.71% 3.22% 3.44%

Drivers of MED's profit

TTM

Net profit attributable to parent increased vs last year, mainly helped by higher gross profit. Supporting and offsetting drivers:

Gross profit ↑ 16.8bn
Administrative expenses ↑ 7.2bn
Tax ↑ 2.5bn
TTM

Net profit attributable to parent increased vs prior quarter, mainly helped by lower administrative expenses. Supporting and offsetting drivers:

Administrative expenses ↓ 3.9bn
Gross profit ↑ 2.1bn
Tax ↑ 0.9bn
Selling expenses ↑ 0.6bn
Finance costs ↑ 0.5bn

Financial Highlights

Detailed analysis of each financial dimension

ROE = Profit Margin × Asset Turnover × Equity Multiplier

2025Q1 4.1% = 3.3% × 0.76 × 1.65
2026Q1 6.3% = 4.7% × 0.97 × 1.40

ROE rose from 4.1% to 6.3% — mainly driven by asset turnover, despite leverage moving in the opposite direction.

Net margin: 4.7% +1.4pp Asset turnover: 0.97x +0.21x Leverage: 1.40x -0.24x

Is the profit sustainable?

Margins are improving and earnings quality is solid — a durable foundation for ROE.

very positive positive stable watch under pressure

What is driving the margin?

Net margin edged up to 4.65%, rising 1.4pp. Core operating signals are improving as Gross margin rose 1.7pp are enough to offset pressure from SG&A / Revenue rose 0.0pp (with lingering pressure from Net financial result / Revenue fell 0.2pp).

The improvement comes from core operations — this is a high-quality margin expansion.

Profitability trend

Net Margin 4.65% +1.4pp
Gross Margin 23.12% +1.7pp
SG&A / Revenue 16.65% +0.0pp

TTM YoY · 2025Q1 -> 2026Q1

Is capital being used efficiently?

Capital is being used more efficiently — ROIC rose and cash cycle shortened to 81.9 days.

Is capital being deployed efficiently?

ROIC expanded to 5.76%, rising 2.0pp. That translates to 5.76 in after-tax operating profit for every 100 units of operating capital. Both NOPAT margin rose 1.2pp and capital turnover rose 0.16x, with invested capital holding roughly steady — capital-return quality improved from both sides.

NOPAT margin led the improvement, but the ROIC level has not yet cleared typical cost of capital — margin needs to hold in coming periods rather than being a one-period rebound.

CAPITAL EFFICIENCY TREND

TTM YoY · 2025Q1 -> 2026Q1

ROIC 5.76% +2.0pp
NOPAT Margin 4.46% +1.2pp
Capital Turnover 1.29x +0.16x
Average Invested Capital 352.5bn −11.8bn

Balance Sheet

ROIC is improving — the asset structure below shows how capital is being allocated. Capital structure is conservative with low leverage — liabilities at 0.38x equity, net debt at 0.06x equity.

Inventory ended the period at 93.2bn, roughly 20.4% of total assets.

Over the last 12 months, working capital absorbed 3.8bn of cash, mainly because of lower payables. Part of that drag was offset by lower receivables and lower inventories.

Working Capital Drivers

TTM YoY · 2025Q1 -> 2026Q1

Receivables decreased → higher CFO: +19.7bn
Inventories decreased → higher CFO: +5.6bn
Payables decreased → lower CFO: −29.0bn

Working Capital Efficiency

Working capital is being managed more efficiently, supporting overall capital efficiency. Cash conversion cycle improved by 33.4 days versus the same period last year. The main moves came from DIO fell 19.5 days, DSO fell 32.2 days, and DPO fell 18.3 days.

Improvement comes mainly from faster receivables collection — reflects the quality of receivables management.

Working Capital Efficiency

TTM YoY · 2025Q1 -> 2026Q1

Receivables 40.3 days −32.2 days
Inventory 88.8 days −19.5 days
Payables 47.2 days −18.3 days
Cash Conversion Cycle 81.9 days −33.4 days

Is financial risk significant?

Check leverage, liquidity, and cash-flow conversion.

Leverage & Liquidity

Leverage looks fairly comfortable, with net debt / equity at 0.06x and interest coverage at 5.49x.

At present, short-term debt accounts for 100.0% of total debt, cash equals 61.0% of debt, and total debt stands at 50.4bn.

Watchpoints

Short-term refinancing pressure is meaningful

Short-term debt accounts for 100.0% of total debt, raising near-term refinancing needs.

Leverage and liquidity trend

Net Debt / Equity 0.06x +0.01x
Interest Coverage 5.49x +1.64x
Cash / Debt 61.0% −8.6pp
Short-term Debt / Total Debt 100.0% 0.0pp
CFO / NI 0.23x −2.25x

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

Operating cash flow reached -5.4bn in 2025, against investing cash flow of -4.0bn.

Post-investment cash flow was negative +9.3bn. Financing cash flow was negative +8.9bn.

CFO / net income was 0.23x.

Track how much investment can be funded internally from operating cash flow.

Cash capex or FCF data is incomplete, so the cash-conversion view is only partial.

Cash Conversion

TTM Cash Conversion · 2025Q1 -> 2026Q1

CFO TTM 4.8bn −28.6bn
Cash Capex
FCF TTM

Investment Takeaway

The business is entering a broader improvement phase — not just stronger earnings but better operating quality as well. Margin, ROIC, and cash flow all improving shows the business is growing in a cleaner and more efficient way than before. Notably, the improvement trend has been confirmed across multiple cycles, from margin to capital efficiency and cash generation. Even so, cash generation still needs confirmation remains the area to verify in upcoming periods.

Improvement: operating efficiency is getting better, with trailing-12M net margin at 4.65% after expanding 1.4pp versus the same period last year.

Watchpoint: Cash generation still needs confirmation.

Statement Data

Item 2025 2024 2023 2022 2021
Net Revenue
366.8 443.1 402.7 401.1 344.0
Cost of Goods Sold
281.0 350.6 319.7 322.6 0.0
Gross Profit
85.8 92.6 83.1 78.4 68.1
Financial Expenses
3.7 5.9 6.7 7.5 -5.5
Selling Expenses
4.7 8.0 12.7 14.4 -16.0
General and Administrative Expenses
58.6 62.4 56.2 54.9 -43.2
Operating Profit
20.1 18.5 15.3 7.4 8.2
Profit Before Tax
20.7 19.4 14.9 8.2 5.5
Net Income
15.8 15.2 11.7 6.0 3.7
Profit Attributable to Parent
15.8 15.2 11.7 6.0 3.7
Earnings per Share
1,276.00 1,229.00 946.00 554.00 581.00

Explore Other Stocks In The Same Sector

DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.